---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-027305"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T04:08:18.560933+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tivic Health adjourns annual meeting to June 14; seeks more votes on reverse split and key proposals

## Summary
- Annual meeting on June 6, 2023 adjourned after only adjournment proposal approved; votes on director election, reverse split (1:5–1:30), and auditor ratification deferred to June 14.
- Reverse stock split proposal authorizes Board to determine ratio within 12 months without further shareholder approval.
- Record date remains April 13, 2023; shareholders urged to vote online at virtualshareholdermeeting.com/TIVC2023.
- CEO needs additional votes for key measures; Board unanimously voted to reconvene on June 14 at 1:00 p.m. PT.

## SEC filing metadata
- accession: 0000950170-23-027305
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017023027305/0000950170-23-027305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017023027305/tivc-20230606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-027305
- JSON: https://secwatch.observer/filing/0000950170-23-027305.json
- Plain text: https://secwatch.observer/filing/0000950170-23-027305.txt

## Key facts
- Shareholder Votes
  Valion Bio, Inc. shareholders approved Adjournment of the Annual Meeting to solicit additional proxies at the 2023-06-06 meeting.
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The sole proposal presented to stockholders and voted on at the Annual Meeting on June 6, 2023 was the Adjournment Proposal, which was approved by the Company’s stockholders. The votes cast at the Annual Meeting with respect to the Adjournment Proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 14,272,410 897,725 53,791 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000095017023027305/0000950170-23-027305-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.